Clinical Rheumatology

, Volume 8, Issue 1, pp 23–28 | Cite as

Anticardiolipin antibodies in patients with infectious diseases

  • M. B. Santiago
  • W. Cossermelli
  • M. F. Tuma
  • M. N. Pinto
  • R. M. Oliveira


IgG or IgM anticardiolipin antibodies were present in the sera of 67% of 33 patients with Hansen 's disease, in 53 % of 30 patients with tuberculosis and in 50% of 16 patients with endocarditis. Despite the high frequency of these antibodies, no patient had a history of thrombosis or abortion. Antidenatured DNA antibodies were tested in patients with tuberculosis and patients with Hansen 's disease. Only in the latter group did we observe a statistically significant association between anticardiolipin and antidenatured DNA antibodies. Anticardiolipin binding activity, however, could not be inhibited by preincubation of sera with a variable concentration of denatured DNA. These data suggest that: a) Anticardiolipin antibodies in infectious diseases do not necessarily participate in the pathogenesis of thrombotic or obstetric complications; b) Anti-denatured DNA and anticardiolipin antibodies in the population studied do not have a crossreaction.

Key words

Anticardiolipin Antibodies Endocarditis Leprosy Tuberculosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Harris, E.N., Gharavi, A.E., Boey, M.L., et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983, 2, 1211–4.PubMedGoogle Scholar
  2. 2.
    Asherson, R.A., Chan, J.K.H., Harris, E.N., Gharavi, A.E., Hughes, G.R.V. Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal. Ann rheum Dis 1985, 44, 823–5.PubMedGoogle Scholar
  3. 3.
    Harris, E.N., Chan, J.K.H., Asherson, R.A., Aber, V.E., Gharavi, A.E., Hughes, G.R.V. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of an anticardiolipin antibody test. Arch Intern Med 1986, 146, 2153–6.PubMedGoogle Scholar
  4. 4.
    Harris, E.N., Gharavi, A.E., Boey, M.L., et al. Anticardiolipin antibodies: Detection by a new solid phase radioimmunoassay: striking association with thrombosis. Ann rheum Dis 1984, 43, 122.Google Scholar
  5. 5.
    Lockshin, M.D., Druzin, M.L., Goei, S., et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. New Engl J Med 1985, 313, 152–6.PubMedGoogle Scholar
  6. 6.
    Lockshin, M.D., Qamar, T., Goei, S., Druzin, M. Anticardiolipin antibody in SLE pregnancy: Prognostic value and response to therapy. Arthritis Rheum 1986, 29 (suppl. 4), S 44.Google Scholar
  7. 7.
    Thornton, J.G., Scott, J.S., Tovey, L.A.D., Anticardiolipin antibodies in pregnancy. Br Med J 1984, 289, 697.Google Scholar
  8. 8.
    Carreras, L.O., Vermylen, J.G. Lupus anticoagulant and thrombosis — Possible role of inhibition of prostacyclin formation. Trombos Haemost 1982, 48, 38–40.Google Scholar
  9. 9.
    Vaarala, O., Palosuo, T., Kleemola, M., Aho, K. Anticardiolipin response in acute infections. Clin Immunol Immunopath 1986, 41, 8–15.PubMedGoogle Scholar
  10. 10.
    Furukawa, F., Kashihara, M., Imamura, S., Ohshio, G., Hamashima, Y. Evaluation of anticardiolipin antibody and its cross-reactivity in sera of patients with lepromatosus leprosy. Arch Dermatol Res 1986, 278, 317–9.PubMedGoogle Scholar
  11. 11.
    Gharavi, A.E., Harris, E.N., Asherson, R.A., Hughes, G.R.V. Anticardiolipin antibodies isotype distribution and phospholipid specificity. Ann Rheum Dis. 1987, 46, 1–6.PubMedGoogle Scholar
  12. 12.
    Canoso, R.T., Oliveira, R.M. Chlorpromazine induced anticardiolipin antibodies and lupus anticoagulant. Arthritis Rheum 1986, 29 (suppl.4), S 96.Google Scholar
  13. 13.
    Schwartz, R.S., Stollar, B.D. Origins of antiDNA autoantibodies. J Clin Invest 1985, 75, 321–7.PubMedGoogle Scholar
  14. 14.
    Cossermelli, W., Santiago, M.B., Bueno, C., Brum Fernandes, A.J., Oliveira, R.M. Cross reactivity of anti-DNA and anticardiolipin antibodies (ACA) in systemic lupus erythematosus (SLE). Clin Exp Rheumatol 1987, 5 (S-2), 174.Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • M. B. Santiago
    • 1
  • W. Cossermelli
    • 1
  • M. F. Tuma
    • 1
  • M. N. Pinto
    • 1
  • R. M. Oliveira
    • 1
  1. 1.Department of Rheumatology, School of MedicineUniversity of São PauloSão PauloBrazil

Personalised recommendations